The Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK-IDDRC) and its programs represent the hub of Einstein's research labs and patient clinics focused on intellectual and developmental disabilities (IDDs). Founded more than 40 years ago, the RFK-IDDRC has long been at the forefront of research on normal and abnormal brain development and function, and of clinical care for children with IDDs. Today, with reinvigorated leadership, the RFK-IDDRC is dissolving barriers between neuroscience and genetic research; fostering new and productive collaborations between basic scientists and clinicians; and advancing knowledge about and treatments for IDDs impacting children.
With access to state-of-the-art equipment and techniques, RFK-IDDRC scientists are leading the way in research on autism, Rett, Fragile X, Niemann-Pick C and other genetic and neurometabolic disorders, on seizure disorders, on deafness and communication disorders and on understanding the impact of the environment and nutrition on brain development and maturation.
Bridges built between RFK-IDDRC investigators and clinicians also are allowing advancement of translational studies designed to bring bench research discoveries to the bedside as new and innovative therapies.